why choose us

First received: March 23, 2023

Clinical Trial: First in Human Study of TLC-ART 101 (ACTU 2001)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Human Immunodeficiency Virus

Study Type: INTERVENTIONAL


Official Title: First in Human Clinical Trial of a Next Generation, Long-acting Injectable, Combination Antiretroviral Therapy Platform

Brief Summary: This study is a prospective, open-label, single-site, first-in-human study of a long-acting, injectable combination antiretroviral therapy platform, with a pharmacologically-guided adaptive design for dose escalation, de-escalation, and study duration.The study is designed to learn whether the formulation can be used as a platform for other drugs for treatment of HIV.The formulation is a drug combination nanoparticle (DCNP).The study will be conducted by UW Positive Research.The sample size for this study is…

Read more